This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
15 Aug 2014

Impressive Growth Leads to Expansion at Biotec Services

Biotec Services International, the global provider of temperature-controlled packaging and distribution services for clinical trials, is doubling its capacity with the addition of new processing facilities, following impressive growth.

 

The UK-headquartered company is expanding into additional operational, packaging and storage facilities on the back of 15% growth in the last year.

 

As a result of increased client demand, which includes a new contract win worth £5 million, Biotec Services is increasing its controlled room temperature storage by 100 per cent and its cold room storage by 400%. It is also creating a second advanced therapeutic medicinal products (ATMP) facility.

 

Providing support to hundreds of clinical trial and commercial projects for clients across the world, Biotec Services has built an impressive reputation for its cold chain  packaging and distribution services across a full temperature range from controlled ambient down to minus 196 °C.

 

Dr Fiona Withey, CEO, said: “We have an exciting pipeline of work and an increasing number of Phase III trials with larger storage requirements, which has resulted in a need to expand our temperature controlled packaging and storage facilities.

 

“Feedback from our recent client survey indicated that refrigerated storage at +2 °C to +8 °C is the range that most suits our partners’ requirements so we are developing our facilities in line with this and also bespoke temperature demands.

 

“The investment demonstrates our continued commitment to developing innovative solutions to meet our clients’ clinical supplies requirements.”

 

As part of the company’s strategic growth plans, it has also acquired land adjacent to the current Biotec Services’ facilities, which will be developed in-line with client demands.

 

Dr Withey, continued: “We have ambitious objectives for the next 3 years as we move towards achieving our vision of becoming the market leader in cold chain clinical trial services, headquartered in the UK with a global presence. We will be looking to continue to develop our services for existing customers and to grow more and more partnerships worldwide, tackling new markets. With these plans in mind, we have secured land adjoining our current facilities to accommodate our future growth.”

Related News